Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DJYB | ISIN: CA75103L1013 | Ticker-Symbol: 7JO
Frankfurt
06.06.25 | 15:29
0,031 Euro
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
RAKOVINA THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
RAKOVINA THERAPEUTICS INC 5-Tage-Chart

Aktuelle News zur RAKOVINA THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
RAKOVINA THERAPEUTICS Aktie jetzt für 0€ handeln
MoRakovina Therapeutics reports Q1 results1
MoRakovina Therapeutics Inc: Rakovina Therapeutics Announces 2025 Q1 Financial Results and Provides Corporate Update123VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) ("Rakovina" or the "Company"), a biopharmaceutical company advancing novel DNA-damage...
► Artikel lesen
29.05.Rakovina Therapeutics Inc: Rakovina to issue shares to some debenture holders1
29.05.Rakovina Therapeutics Inc: Rakovina Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations81VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) ("Rakovina" or the "Company") announces that in accordance with the terms of an indenture...
► Artikel lesen
16.05.Rakovina Therapeutics Inc: Rakovina Therapeutics arranges $4-million financing1
15.05.Rakovina Therapeutics announces financing, share consolidation2
15.05.Rakovina Therapeutics Inc: Rakovina Therapeutics Announces Strategic Private Placement, Convertible Debt Financing, and Share Consolidation to Accelerate US-Focused Growth and AI-Powered Oncology Innovation53VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) ("Rakovina" or the "Company"), a biopharmaceutical company advancing innovative cancer...
► Artikel lesen
06.05.Rakovina Therapeutics Inc: Rakovina appoints Kideckel as CFO2
05.05.Rakovina Therapeutics names David Kideckel as CFO3
05.05.Rakovina Therapeutics Inc: Rakovina Therapeutics Announces Appointment of Dr. David Kideckel as Chief Financial Officer111VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) ("Rakovina" or the "Company"), a biopharmaceutical company advancing innovative cancer...
► Artikel lesen
30.04.Rakovina Therapeutics Inc. Announces 2024 Financial Results and Provides Corporate Update80VANCOUVER, British Columbia, April 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing next-generation cancer therapies through artificial...
► Artikel lesen
30.04.Rakovina Therapeutics Inc: Rakovina appoints Meshcherekov, Kideckel as directors1
30.04.Rakovina Therapeutics Inc: Rakovina Strengthens Board with Appointments of Yevgeniy Meshcherekov and David Kideckel79VANCOUVER, British Columbia, April 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through artificial...
► Artikel lesen
29.04.Rakovina Therapeutics Inc: Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 20252
22.04.Rakovina Therapeutics Inc: Rakovina Therapeutics Congratulates Scientific Advisor Dr. Artem Cherkasov on Global Recognition for Breakthrough AI Innovation in Drug Discovery1
02.04.Original-Research: Rakovina Therapeutics Inc. (von First Berlin Equity Research GmbH): Initiation of coverage - Buy227Original-Research: Rakovina Therapeutics Inc. - from First Berlin Equity Research GmbH 02.04.2025 / 15:31 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group....
► Artikel lesen
25.03.Rakovina Therapeutics Inc: Rakovina abstracts to be presented at research meeting1
12.03.Rakovina Therapeutics Inc: Rakovina receives batch of AI-generated ATR compounds2
12.03.Rakovina Therapeutics advances AI-designed cancer drugs1
12.03.Rakovina Therapeutics Inc: Next-Gen Cancer Treatment: Rakovina's AI-Driven ATR Inhibitors Enter Preclinical Testing189VANCOUVER, British Columbia, March 12, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV)(FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through artificial...
► Artikel lesen
Weiter >>
41 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1